Calpain mediates the dioxin-induced activation and down-regulation of the aryl hydrocarbon receptor

Molecular Pharmacology

Volumn 70, Issue 5, 2006, Pages 1481-1487

  Dale, Yolanda R ^a   Eltom, Sakina E ^a,b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER; AROMATIC HYDROCARBON RECEPTOR; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALCIUM; CALPAIN; CALPASTATIN; CYTOCHROME P450 1A1; DIOXIN; EPOXOMICIN; PD 150606; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; CALCIUM; CALPAIN; CELL NUCLEUS; CYTOCHROME P-450 CYP1A1; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 33751181032     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.027474     Document Type: Article

References (38)

1. Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S, Hanberg A, and Poellinger L (2002) A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci USA 99:9990-9995.
2. Band V, Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C, Connolly J, and Sager R (1990) Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 50:7351-7357.
3. Bang B, Baadsgaard O, Skov L, and Jaattela M (2004) Inhibitors of cysteine cathepsin and calpain do not prevent ultraviolet-B-induced apoptosis in human keratinocytes and HeLa cells. Arch Dermatol Res 296:67-73.
4. Carragher NO, Fonseca BD, and Frame MC (2004) Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia 6:53-73.
5. Carver LA and Bradfield CA (1997) Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 272:11452-11456.
6. Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res 42:4875-4917.
7. Davarinos NA and Pollenz RS (1999) Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J Biol Chem 274:28708-28715.
8. Eltom SE, Zhang L, and Jefcoate CR (1999) Regulation of cytochrome P-450 (CYP) 1B1 in mouse Hepa-1 variant cell lines: A possible role for aryl hydrocarbon receptor nuclear translocator (ARNT) as a suppressor of CYP1B1 gene expression. Mol Pharmacol 55:594-604.
9. Goasduff T, Dreano Y, Guillois B, Menez JF, and Berthou F (1996) Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem Pharmacol 52:1915-1919.
10. Gonzalez FJ, Mackenzie PI, Kimura S, and Nebert DW (1984) Isolation and characterization of full-length mouse cDNA and genomic clones of 3-methylcholanthrene-inducible cytochrome P1-450 and P3-450. Gene 29:281-292.
11. Hanneman WH, Legare ME, Barhoumi R, Burghardt RC, Safe S, and Tiffany-Castiglioni E (1996) Stimulation of calcium uptake in cultured rat hippocampal neurons by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 112:19-28.
12. Jones PB, Galeazzi DR, Fisher JM, and Whitlock JP Jr (1985) Control of cytochrome P1-450 gene expression by dioxin. Science (Wash DC) 227:1499-1502.
13. Kazlauskas A, Sundstrom S, Poellinger L, and Pongratz I (2001) The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor. Mol Cell Biol 21:2594-2607.
14. Koliopanos A, Kleeff J, Xiao Y, Safe S, Zimmermann A, Buchler MW, and Friess H (2002) Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene 21:6059-6070.
15. Kumar MB, Ramadoss P, Reen RK, Vanden Heuvel JP, and Perdew GH (2001) The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity. J Biol Chem 276:42302-42310.
16. Le Ferrec E, Lagadic-Gossmann D, Rauch C, Bardiau C, Maheo K, Massiere F, Le Vee M, Guillouzo A, and Morel F (2002) Transcriptional induction of CYP1A1 by oltipraz in human Caco-2 cells is aryl hydrocarbon receptor- and calcium-dependent. J Biol Chem 277:24780-24787.
17. Ma Q and Whitlock JP Jr (1997) A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 272:8878-8884.
18. Mailhes JB, Hilliard C, Lowery M, and London SN (2002) MG-132, an inhibitor of proteasomes and calpains, induced inhibition of oocyte maturation and aneuploidy in mouse oocytes. Cell Chromosome 1:2.
19. Mathiasen IS, Sergeev IN, Bastholm L, Elling F, Norman AW, and Jaattela M (2002) Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem 277:30738-30745.
20. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, and Crews CM (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci USA 96:10403-10408.
21. Meyer BK and Perdew GH (1999) Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 38:8907-8917.
22. 2+-dependent proteolysis of the Ah receptor. Arch Biochem Biophys 261:103-111.
23. Poland A and Glover E (1990) Characterization and strain distribution pattern of the murine Ah receptor specified by the Ahd and Ahb-3 alleles. Mol Pharmacol 38:306-312.
24. Poland A and Knutson JC (1982) 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22:517-554.
25. Pollenz RS (1996) The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p- dioxin. Mol Pharmacol 49:391-398.
26. Pollenz RS, Sattler CA, and Poland A (1994) The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol Pharmacol 45:428-438.
27. Potter DA, Tirnauer JS, Janssen R, Croall DE, Hughes CN, Fiacco KA, Mier JW, Maki M, and Herman IM (1998) Calpain regulates actin remodeling during cell spreading. J Cell Biol 141:647-662.
28. Prokipcak RD and Okey AB (1991) Downregulation of the Ah receptor in mouse hepatoma cells treated in culture with 2,3,7,8-tetrachlorodibenzo-p- dioxin. Can J Physiol Pharmacol 69:1204-1210.
29. Quattrochi LC and Tukey RH (1993) Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene. Mol Pharmacol 43:504-508.
30. Reick M, Robertson RW, Pasco DS, and Fagan JB (1994) Down-regulation of nuclear aryl hydrocarbon receptor DNA-binding and transactivation functions: requirement for a labile or inducible factor. Mol Cell Biol 14:5653-5660.
31. 2+ concentration. Proc Natl Acad Sci USA 87:1825-1829.
32. Sadek CM and Allen-Hoffmann BL (1994) Cytochrome P450IA1 is rapidly induced in normal human keratinocytes in the absence of xenobiotics. J Biol Chem 269:16067-16074.
33. Scholler A, Hong NJ, Bischer P, and Reiners JJ Jr (1994) Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole. Mol Pharmacol 45:944-954.
34. Song Z and Pollenz RS (2002) Ligand-dependent and independent modulation of aryl hydrocarbon receptor localization, degradation, and gene regulation. Mol Pharmacol 62:806-816.
35. 2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis 18:1177-1182.
36. Wang KK (1990) Developing selective inhibitors of calpain. Trends Pharmacol Sci 11:139-142.
37. Wang KK, Villalobo A, and Roufogalis BD (1989) Calmodulin-binding proteins as calpain substrates. Biochem J 262:693-706.
38. Whitlock JP Jr (1999) Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39:103-125.